Citichem India Ltd
Incorporated in 1992, Citichem India Limited is engaged in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the pharmaceutical industry.[1]
- Market Cap ₹ 18.5 Cr.
- Current Price ₹ 27.1
- High / Low ₹ 70.0 / 25.0
- Stock P/E 15.0
- Book Value ₹ 29.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 8.91 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.92 times its book value
- Company's working capital requirements have reduced from 107 days to 58.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -22.0%
- The company has delivered a poor sales growth of -15.6% over past five years.
- Company has a low return on equity of 11.2% over last 3 years.
- Contingent liabilities of Rs.21.4 Cr.
- Company has high debtors of 343 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Trading - Chemicals
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.00 | 127.35 | 180.17 | 85.22 | 20.94 | 19.61 | 54.37 | |
| 0.02 | 127.07 | 179.96 | 84.84 | 20.36 | 17.81 | 52.75 | |
| Operating Profit | -0.02 | 0.28 | 0.21 | 0.38 | 0.58 | 1.80 | 1.62 |
| OPM % | 0.22% | 0.12% | 0.45% | 2.77% | 9.18% | 2.98% | |
| 0.00 | 0.01 | 0.11 | 0.06 | 0.00 | 0.00 | 0.36 | |
| Interest | 0.00 | 0.01 | 0.00 | 0.10 | 0.06 | 0.07 | 0.31 |
| Depreciation | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
| Profit before tax | -0.02 | 0.27 | 0.30 | 0.32 | 0.51 | 1.71 | 1.66 |
| Tax % | 0.00% | 25.93% | 26.67% | 28.12% | 29.41% | 18.71% | 25.90% |
| -0.02 | 0.20 | 0.22 | 0.24 | 0.36 | 1.39 | 1.23 | |
| EPS in Rs | 0.48 | 0.72 | 2.78 | 1.81 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -16% |
| 3 Years: | -14% |
| TTM: | 177% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 44% |
| 3 Years: | 72% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 11% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.07 | 0.07 | 0.07 | 5.00 | 5.00 | 5.00 | 6.80 |
| Reserves | 0.15 | 0.31 | 0.53 | 0.77 | 1.13 | 2.52 | 13.30 |
| 0.11 | 0.37 | 0.00 | 1.11 | 1.10 | 1.08 | 5.39 | |
| 0.01 | 31.98 | 72.62 | 84.55 | 72.50 | 60.73 | 44.43 | |
| Total Liabilities | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 |
| 0.01 | 0.08 | 0.09 | 0.08 | 0.10 | 0.10 | 0.06 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.32 | 32.64 | 73.13 | 91.35 | 79.63 | 69.23 | 69.86 | |
| Total Assets | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.37 | 0.38 | -5.95 | 0.28 | 0.49 | -11.51 | ||
| -0.01 | -0.02 | -0.01 | -0.04 | 0.00 | 0.03 | ||
| -0.42 | -0.37 | 5.94 | -0.07 | -0.08 | 15.35 | ||
| Net Cash Flow | -0.07 | -0.02 | -0.03 | 0.17 | 0.41 | 3.86 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 5.53 | 68.05 | 198.73 | 595.78 | 569.18 | 342.91 | |
| Inventory Days | 76.06 | 70.95 | 180.36 | 857.35 | 849.40 | 45.66 | |
| Days Payable | 92.27 | 148.47 | 367.79 | 1,378.23 | 1,348.08 | 315.43 | |
| Cash Conversion Cycle | -10.68 | -9.47 | 11.30 | 74.90 | 70.51 | 73.15 | |
| Working Capital Days | 1.63 | 0.85 | 28.70 | 118.01 | 144.99 | 58.20 | |
| ROCE % | 44.44% | 11.23% | 8.08% | 22.49% | 11.56% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct - AGM (30 Sep 2025) approved increase in authorised capital to INR125mn and issuance of 4,700,000 convertible warrants.
-
Intimations Under Regulation 30
1 Oct - AGM approved authorised capital increase to INR125,000,000 and issue 4,700,000 warrants at INR28 each (INR13.16Cr).
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
1 Oct - AGM approved FY2025 financials; authorised capital increased INR75,000,000→INR125,000,000; up to 4,700,000 preferential convertible warrants.
-
Reg. 34 (1) Annual Report.
9 Sep - AGM on 30 Sep 2025: increase authorised capital to INR125m; preferential issuance of 4.7M warrants raising INR131.6m.
-
Notice Of 33Rd Annual General Meeting Scheduled To Be Held On Tuesday, 30Th September, 2025
8 Sep - AGM 30 Sep 2025; increase authorised capital by Rs5 crore; preferential issue 4.7M warrants at Rs28 (Rs13.16 crore).
Business Overview[1]
Citichem India Limited is engaged in trading and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to various industries, including pharmaceuticals, aluminum, steel, textiles, paper, dairy, paints, dyes, soaps, and adhesives.